A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

New data from the American Cancer Society reveals a historic survival milestone even as federal funding faces potential cuts.

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

Historic redlining, a U.S. policy outlawed nearly 6 decades ago for segregating neighborhoods based on their racial makeup, still negatively impacts survival from breast cancer, according to results ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Researchers at Fondazione Policlinico Universitario Agostino Gemelli IRCCS have developed a promising machine learning algorithm capable of predicting survival and cause of death for patients with ...

The Young Survival Coalition is answering questions on everything from fertility to family genetics during a New Orleans summit.

Grade 1 breast cancer is the least aggressive form of breast cancer and often has an excellent prognosis if detected early. Experts say regular screening, including mammograms and breast exams, helps ...